Skip to main content
DSM
NYSE Unknown

BNY Mellon Fund Urges Shareholders to Reject Activist Nominee in Proxy Fight

Arie Shkolnikov · Analysis by Wiseek AI
Sentiment info
Negative
Importance info
7
Price
$6.17
Mkt Cap
$301.515M
52W Low
$5.445
52W High
$6.3
52W Position info
13% above low
Off High info
2.1% below high
Rel. Volume info
1.6× avg
Market data snapshot near publication time

DSM is trading near its 52-week low of $5.445 (13% above the low).

Summary

BNY Mellon Strategic Municipal Bond Fund is actively soliciting shareholder votes to re-elect its current Directors and reject a nominee from activist investor Saba Capital Management, citing potential risks to the Fund's investment objective.


Key Events · Corporate Governance and Compliance · DSM

  • Proxy Contest Escalates

    The Fund is actively campaigning against activist investor Saba Capital Management's director nominee.

  • Board Recommends Incumbents

    The Board unanimously recommends voting FOR its current Directors using the WHITE proxy card.

  • Warning Against Activist Nominee

    The Fund warns that Saba's nominee could imperil the Fund's investment objective and income generation.

  • Urges Discarding Opposing Proxy

    Shareholders are explicitly urged to discard any GOLD proxy cards received from Saba.


Analysis · DSM · Unknown

This DEFA14A filing serves as additional definitive proxy material, intensifying the ongoing proxy contest between BNY Mellon Strategic Municipal Bond Fund and activist investor Saba Capital Management. The Fund's Board is strongly urging shareholders to vote for its incumbent Directors using the WHITE proxy card and to discard any GOLD proxy cards from Saba. The Board explicitly warns that Saba's nominee could jeopardize the Fund's ability to meet its investment objective and generate consistent income. This indicates a contentious battle for control or influence over the Fund's strategy, which could lead to significant changes depending on the outcome of the June 11, 2026, annual meeting. Investors should monitor developments closely as the proxy fight unfolds.

At the time of this filing, DSM was trading at $6.17 on NYSE in the Unknown sector, with a market capitalization of approximately $301.5M. The 52-week trading range was $5.45 to $6.30. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

DSM - Latest Insights

DSM
Jun 05, 2026, 4:01 PM EDT
Filing Type: DEFA14A
Importance Score:
8
Price at Filing: $6.10
Real-time Price: $5.87 info
Change: -$0.230 (-4%) info
Market Cap: $291.135M info
DSM
Jun 03, 2026, 5:35 PM EDT
Filing Type: DEFA14A
Importance Score:
8
Price at Filing: $6.10
Real-time Price: $5.87 info
Change: -$0.230 (-4%) info
Market Cap: $291.135M info
DSM
May 18, 2026, 4:25 PM EDT
Filing Type: DEFA14A
Importance Score:
8
Price at Filing: $6.00
Real-time Price: $5.87 info
Change: -$0.130 (-2%) info
Market Cap: $291.135M info
DSM
May 07, 2026, 10:00 AM EDT
Filing Type: DFAN14A
Importance Score:
9
Price at Filing: $6.18
Real-time Price: $5.87 info
Change: -$0.310 (-5%) info
Market Cap: $291.135M info
DSM
Apr 29, 2026, 3:45 PM EDT
Filing Type: DEFC14A
Importance Score:
8
Price at Filing: $6.00
Real-time Price: $5.87 info
Change: -$0.130 (-2%) info
Market Cap: $291.135M info